Hone D, Attridge S, van den Bosch L, Hackett J
Department of Microbiology and Immunology, University of Adelaide, Australia.
Microb Pathog. 1988 Dec;5(6):407-18. doi: 10.1016/0882-4010(88)90002-2.
We have developed a system whereby heterologous DNA encoding an antigen from an enteropathogen may be recombined into the chromosome of an attenuated Salmonella carrier strain. The system involves two steps: (i) integration of a hisOG deletion mutation into the chromosome; (ii) replacement of the hisOG deletion by the complete hisOG region and the segment of heterologous DNA which encodes the antigen of interest. Recombinants may be selected (his+). The system was used to integrate the genes encoding K88 fimbriae from enterotoxigenic Escherichia coli into the chromosome of a galE mutant of Salmonella typhimurium (LT2H1). Recombinants were detected at a frequency of between 1.0 x 10(-3) and 1.5 x 10(-3). A variety of tests confirmed that the K88 genes were integrated into the chromosome of LT2H1 and were expressed. The stability of the recombinant was tested both in vivo and in vitro. When administered orally to mice, the recombinant elicited a serum antibody response to K88, and retained the Salmonella vaccine potential of the vector strain.
我们已经开发出一种系统,通过该系统,编码来自肠道病原体抗原的异源DNA可以重组到减毒沙门氏菌载体菌株的染色体中。该系统包括两个步骤:(i)将hisOG缺失突变整合到染色体中;(ii)用完整的hisOG区域和编码感兴趣抗原的异源DNA片段替换hisOG缺失。可以选择重组体(his+)。该系统用于将编码产肠毒素大肠杆菌K88菌毛的基因整合到鼠伤寒沙门氏菌(LT2H1)的galE突变体的染色体中。重组体的检测频率在1.0×10(-3)至1.5×10(-3)之间。各种测试证实,K88基因已整合到LT2H1的染色体中并得到表达。在体内和体外对重组体的稳定性进行了测试。当口服给予小鼠时,重组体引发了针对K88的血清抗体反应,并保留了载体菌株的沙门氏菌疫苗潜力。